Former Chief Commercial Officer · STANDARD BIOTOOLS INC. (LAB)

Colin McCracken

A named executive officer of STANDARD BIOTOOLS in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,386,353

Salary $387,866Stock awards $943,584

FY2020: $1,657,454

2nd of 5 named executive officers at Standard Biotools by FY2021 total.

5 named officers on file for STANDARD BIOTOOLS, FY2021

Colin McCracken’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • LAB’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how STANDARD BIOTOOLS’s whole pay program stands against its peers

  • STANDARD BIOTOOLS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Colin McCracken’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Colin McCracken compensation by year

STANDARD BIOTOOLS Summary Compensation Table · all 3 fiscal years held
In US dollars, as STANDARD BIOTOOLS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$246,800$318,780$387,866
Bonus$0$0$0
Stock awards$1,504,474$922,678$943,584
Option awards$0$0$0
Non-equity incentive$35,326$307,004$0
Pension and deferred compensation$0$0$0
All other$125,164$108,992$54,903
Total$1,911,764$1,657,454$1,386,353

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STANDARD BIOTOOLS INC. DEF 14A filed April 29, 2022, accession 0001162194-22-000050, and prior-year filings. Open the filing on EDGAR.

How this page was built: the STANDARD BIOTOOLS INC. filed document, accession 0001162194-22-000050. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$1.9M
$1.7M
$1.4M
FY19
FY20
FY21
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU68,478$268,434—
RSU65,792$257,905—
RSU60,000$235,200—
PSU46,750$183,260—
PSU25,500$99,960—
RSU21,517$84,347—
RSU15,587$61,101—
RSU9,188$36,017—

Per the Outstanding Equity Awards at Fiscal Year-End table in STANDARD BIOTOOLS INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

STANDARD BIOTOOLS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Stephen LinthwaiteFormer President and CEO$3,311,663
Colin McCracken · this pageFormer Chief Commercial Officer$1,386,353
Vikram JogChief Financial Officer$1,105,664
Nicholas KhadderSenior Vice President, General Counsel, and Secretary$920,559
Bradley KregerSenior Vice President, Global Operations$894,346

The full STANDARD BIOTOOLS compensation record

free company brief

This page is one person within STANDARD BIOTOOLS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STANDARD BIOTOOLS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Colin McCracken's compensation dossier · One-time report. No refunds.